AMOREPACIFIC Holdings Corp. (002790.KS)
Seoul, KR
AMOREPACIFIC Holdings Corp., through its subsidiaries, engages in manufacturing, marketing, and trading of cosmetics, household goods, and health functional foods in Korea, Asia, North America, and internationally. The company offers perfumes, medical and inner beauty products, beauty devices, haircare, body care, and dental care products. It also provides tea culture products. The company was formerly known as AMOREPACIFIC Group and changed its name to AMOREPACIFIC Holdings Corp. in April 2025. AMOREPACIFIC Holdings Corp. was incorporated in 1945 and is headquartered in Seoul, South Korea.
No mergers or acquisitions recorded for this company.
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| +0.88% | -6.34% | -20.35% | -26.95% | -19.51% | -21.03% | -11.58% | -22.90% | -70.53% | -86.25% | +1,607.44% |
Revenue flow
Revenue by geography
Revenue by segment
Revenue composition
By product
By geography
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
DCF figures are point estimates: small changes in growth or discount-rate assumptions move them materially. Read them as a reference, not a precise target.
| Rating | 2026-05 | Change |
|---|---|---|
| Strong Buy | 1 | 0 |
| Buy | 1 | 0 |
| Hold | 0 | 0 |
| Sell | 0 | 0 |
| Strong Sell | 0 | 0 |
-
Revenue growth Household & Personal Products: +3.3%+8.5% ★ Q1'26: +5.0% (vs Q1'25)
-
EPS growth Household & Personal Products: +8.8%-54.9% Q1'26: -4.2% (vs Q1'25)
-
FCF margin FCF growth · Household & Personal Products: +44.8%+9.9% Q1'26: +11.3% (vs Q1'25)
-
EBIT margin Household & Personal Products: +9.9%+8.0% Q1'26: +11.3% (vs Q1'25)
-
ROIC Household & Personal Products: +8.2%+4.8% Q1'26: +7.5% (vs Q1'25)
-
Share dilution Household & Personal Products: +0.2%+146.1% Q1'26: +137.5% (vs Q1'25)
-
Debt / EBITDA Net debt/EBITDA · Household & Personal Products: -0.51×0.53× ★ Q1'26: 0.43× (vs Q1'25)
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
| Metric |
Dec 2015 actual |
Dec 2016 actual |
Dec 2017 actual |
Dec 2018 actual |
Dec 2019 actual |
Dec 2020 actual |
Dec 2021 actual |
Dec 2022 actual |
Dec 2023 actual |
Dec 2024 actual |
Dec 2025 actual |
Dec 2026 2 Rev. Ana. 2 EPS Ana. |
Dec 2027 2 Rev. Ana. 2 EPS Ana. |
Dec 2028 1 Rev. Ana. 1 EPS Ana. |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue |
5.66T
est: 5.65T (+0.3%)
|
6.70T
est: 6.85T (-2.2%)
|
6.03T
est: 6.08T (-0.8%)
|
6.08T
est: 6.13T (-0.9%)
|
6.28T
est: 6.27T (+0.3%)
|
4.93T
est: 4.94T (-0.2%)
|
5.33T
est: 5.17T (+3.0%)
|
4.49T
est: 4.46T (+0.7%)
|
4.02T
est: 4.14T (-2.9%)
|
4.26T
est: 4.23T (+0.8%)
|
4.62T
est: 4.63T (-0.1%)
|
5.00T
4.98T – 5.03T
+8.1% YoY
|
5.35T
5.34T – 5.35T
+6.8% YoY
|
5.69T
5.67T – 5.71T
+6.4% YoY
|
| EBITDA |
1.10T
est: 896.31B (+23.0%)
|
1.30T
est: 1.09T (+19.9%)
|
970.22B
est: 965.07B (+0.5%)
|
849.02B
est: 973.63B (-12.8%)
|
1.04T
est: 994.90B (+4.0%)
|
586.79B
est: 784.20B (-25.2%)
|
852.71B
est: 820.83B (+3.9%)
|
613.87B
est: 708.47B (-13.4%)
|
588.30B
est: 657.77B (-10.6%)
|
987.24B
est: 716.63B (+37.8%)
|
647.81B
est: 785.21B (-17.5%)
|
848.72B
844.54B – 852.91B
+8.1% YoY
|
906.73B
905.47B – 907.99B
+6.8% YoY
|
964.91B
961.91B – 967.90B
+6.4% YoY
|
| EBIT |
925.00B
est: 461.36B (+100.5%)
|
1.09T
est: 559.79B (+95.2%)
|
701.92B
est: 496.76B (+41.3%)
|
538.46B
est: 501.16B (+7.4%)
|
457.12B
est: 512.11B (-10.7%)
|
52.82B
est: 403.65B (-86.9%)
|
438.24B
est: 422.51B (+3.7%)
|
291.17B
est: 364.68B (-20.2%)
|
329.11B
est: 338.58B (-2.8%)
|
719.72B
est: 548.59B (+31.2%)
|
368.00B
est: 601.08B (-38.8%)
|
649.71B
646.50B – 652.91B
+8.1% YoY
|
694.11B
693.14B – 695.08B
+6.8% YoY
|
738.64B
736.35B – 740.93B
+6.4% YoY
|
| Net Income |
260.44B
est: 266.95B (-2.4%)
|
342.39B
est: 362.69B (-5.6%)
|
202.61B
est: 210.37B (-3.7%)
|
142.29B
est: 180.40B (-21.1%)
|
282.40B
est: 169.10B (+67.0%)
|
10.38B
est: 37.52B (-72.3%)
|
180.00B
est: 197.36B (-8.8%)
|
62.24B
est: 108.90B (-42.8%)
|
119.30B
est: 109.37B (+9.1%)
|
252.03B
est: 693.68B (-63.7%)
|
124.04B
est: 585.59B (-78.8%)
|
651.71B
615.66B – 687.75B
+11.3% YoY
|
890.10B
859.67B – 920.52B
+36.6% YoY
|
1.05T
1.05T – 1.05T
+18.0% YoY
|
| SGA |
2.47T
est: 2.57T (-3.8%)
|
2.97T
est: 3.12T (-4.9%)
|
2.74T
est: 2.77T (-1.1%)
|
2.88T
est: 2.79T (+3.0%)
|
2.81T
est: 2.85T (-1.7%)
|
2.09T
est: 2.25T (-6.9%)
|
2.31T
est: 2.36T (-1.9%)
|
1.84T
est: 2.03T (-9.3%)
|
2.39T
est: 1.89T (+26.6%)
|
1.76T
est: 1.90T (-7.3%)
|
1.84T
est: 2.08T (-11.8%)
|
2.25T
2.24T – 2.26T
+8.1% YoY
|
2.41T
2.40T – 2.41T
+6.8% YoY
|
2.56T
2.55T – 2.57T
+6.4% YoY
|
| EPS |
3,219.00
est: 3,230.00 (-0.3%)
|
4,240.00
est: 4,388.42 (-3.4%)
|
2,432.00
est: 2,545.40 (-4.5%)
|
1,708.33
est: 2,182.82 (-21.7%)
|
3,409.48
est: 2,046.10 (+66.6%)
|
125.64
est: 453.95 (-72.3%)
|
1,989.00
est: 2,388.04 (-16.7%)
|
657.00
est: 1,317.62 (-50.1%)
|
1,296.00
est: 1,323.29 (-2.1%)
|
2,781.91
est: 3,410.38 (-18.4%)
|
1,255.57
est: 2,878.95 (-56.4%)
|
3,204.00
3,026.80 – 3,381.20
+11.3% YoY
|
4,376.00
4,226.41 – 4,525.59
+36.6% YoY
|
5,164.00
5,143.18 – 5,184.82
+18.0% YoY
|
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-29 | B | 3/5 | 5/5 | 2/5 | 3/5 | 3/5 | 1/5 | 3/5 |
| 2026-05-28 | B | 3/5 | 5/5 | 2/5 | 3/5 | 3/5 | 1/5 | 3/5 |
| 2026-05-27 | B | 3/5 | 5/5 | 2/5 | 3/5 | 3/5 | 1/5 | 3/5 |
| 2026-05-26 | B | 3/5 | 5/5 | 2/5 | 3/5 | 3/5 | 1/5 | 3/5 |
| 2026-05-22 | B | 3/5 | 5/5 | 2/5 | 3/5 | 3/5 | 1/5 | 3/5 |
| 2026-05-21 | B | 3/5 | 5/5 | 2/5 | 3/5 | 3/5 | 1/5 | 3/5 |
| 2026-05-20 | B | 3/5 | 5/5 | 2/5 | 3/5 | 3/5 | 1/5 | 3/5 |
| 2026-05-19 | B | 3/5 | 5/5 | 2/5 | 3/5 | 3/5 | 1/5 | 3/5 |
| 2026-05-18 | B | 3/5 | 5/5 | 2/5 | 3/5 | 3/5 | 1/5 | 3/5 |
| 2026-05-15 | C | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 |
| 2026-05-14 | C | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 |
| 2026-05-13 | C | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 |
| 2026-05-12 | C | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 |
| 2026-05-11 | C | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 |
| 2026-05-08 | C | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 |
| 2026-05-07 | C | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 |
| 2026-05-06 | C | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 |
| 2026-05-04 | C | 2/5 | 4/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 |
| 2026-04-30 | C | 2/5 | 4/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 |
| 2026-04-29 | B- | 2/5 | 4/5 | 2/5 | 3/5 | 2/5 | 1/5 | 2/5 |
| 2026-04-28 | B- | 2/5 | 4/5 | 2/5 | 3/5 | 2/5 | 1/5 | 2/5 |
| 2026-04-27 | B- | 3/5 | 4/5 | 2/5 | 4/5 | 2/5 | 1/5 | 2/5 |
| 2026-04-24 | B- | 3/5 | 4/5 | 2/5 | 4/5 | 2/5 | 1/5 | 2/5 |
| 2026-04-23 | B- | 3/5 | 4/5 | 2/5 | 4/5 | 2/5 | 1/5 | 2/5 |
| 2026-04-22 | B- | 3/5 | 4/5 | 2/5 | 4/5 | 2/5 | 1/5 | 2/5 |
| 2026-04-21 | B- | 3/5 | 4/5 | 2/5 | 4/5 | 2/5 | 1/5 | 2/5 |
| 2026-04-20 | B- | 3/5 | 4/5 | 2/5 | 4/5 | 2/5 | 1/5 | 2/5 |
| 2026-04-17 | B- | 3/5 | 4/5 | 2/5 | 4/5 | 2/5 | 1/5 | 2/5 |
| 2026-04-16 | B- | 3/5 | 4/5 | 2/5 | 4/5 | 2/5 | 1/5 | 2/5 |
| 2026-04-15 | B- | 3/5 | 4/5 | 2/5 | 4/5 | 2/5 | 1/5 | 2/5 |
Owner Earnings
Ownership Overview
Ownership breakdown not available.
No beneficial ownership filings recorded.
Institutional Activity (13F)
Institutional history not available.
Top holders not available.
Insider Activity
No insider activity available.
Insider history not available.
No recent insider transactions.
Executive team
Executive compensation
Executive compensation not available.
No CEO compensation history available.
Proxy statements
No proxy statements available for this company yet.
Recent SEC filings
No SEC filings available for this company yet.
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Kyungbae Suh | Chief Executive Officer & Chairman | 950M | male |
| Seunghwan Kim | Chief Executive Officer, Executive Vice President of Strategy Unit & Executive Director | 715M | male |
| Genebong Kim | Chief Compliance Officer & Head of Legal Division | — | — |
| Hyung-Kwon Jung | Executive Vice President of HR Unit | — | male |
No data available for this company.
No Senate trading activity found for this company.
No House trading activity found for this company.
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for 002790.KS
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.

MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
